Boechat, A.L., Pessoa, B., Soares, C., Barroso, C., Vila, D., Barbosa, E., Seffair, I., Melo, J.V., Becil, J., Rebouças, M.P., Rodrigues, N., Freitas, P.H., Rocha, R., Rodrigues, T., Ferreira, V., Ubiera, R., & Dos-Santos, M.C. (2020). SARS-CoV-2 and Covid-19 Immunopathogenesis. Preprints. https://doi.org/10.20944/preprints202008.0020.v1
Boechat, A.L., Rosmery Ubiera and Maria Cristina Dos-Santos. 2020 "SARS-CoV-2 and Covid-19 Immunopathogenesis" Preprints. https://doi.org/10.20944/preprints202008.0020.v1
The coronavirus disease 2019 (COVID-19) is now a global pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Unlike other known coronaviruses, such as the Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 reveals new clinical, immunological, and pathologic features. The lymphocyte depletion, macrophage and neutrophil hyperactivation, cytokine dysregulation, thrombophilia, delayed antiviral response, and immune exhaustion are key immunological findings linked to the clinical progression of this disease. Understanding and identifying the underlying immunological basis of COVID-19 is crucial to designing effective therapies. Here, we provide an overview of immunopathogenesis driven by SARS-CoV-2 after its interactions with the immune system.
Biology and Life Sciences, Immunology and Microbiology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.